Unknown

Dataset Information

0

Discovery of siRNA lipid nanoparticles to transfect suspension leukemia cells and provide in vivo delivery capability.


ABSTRACT: As a powerful research tool, siRNA's therapeutic and target validation utility with leukemia cells and long-term gene knockdown is severely restricted by the lack of omnipotent, safe, stable, and convenient delivery. Here, we detail our discovery of siRNA-containing lipid nanoparticles (LNPs) able to effectively transfect several leukemia and difficult-to-transfect adherent cell lines also providing in vivo delivery to mouse spleen and bone marrow tissues through tail-vein administration. We disclose a series of novel structurally related lipids accounting for the superior transfection ability, and reveal a correlation between expression of Caveolins and successful transfection. These LNPs, bearing low toxicity and long stability of >6 months, are ideal for continuous long-term dosing. Our discovery represents the first effective siRNA-containing LNPs for leukemia cells, which not only enables high-throughput siRNA screening with leukemia cells and difficult-to-transfect adherent cells but also paves the way for the development of therapeutic siRNA for leukemia treatment.

SUBMITTER: He W 

PROVIDER: S-EPMC3916034 | biostudies-literature | 2014 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Discovery of siRNA lipid nanoparticles to transfect suspension leukemia cells and provide in vivo delivery capability.

He Wei W   Bennett Michael J MJ   Luistro Leopoldo L   Carvajal Daisy D   Nevins Thomas T   Smith Melissa M   Tyagi Gaurav G   Cai James J   Wei Xin X   Lin Tai-An TA   Heimbrook David C DC   Packman Kathryn K   Boylan John F JF  

Molecular therapy : the journal of the American Society of Gene Therapy 20130903 2


As a powerful research tool, siRNA's therapeutic and target validation utility with leukemia cells and long-term gene knockdown is severely restricted by the lack of omnipotent, safe, stable, and convenient delivery. Here, we detail our discovery of siRNA-containing lipid nanoparticles (LNPs) able to effectively transfect several leukemia and difficult-to-transfect adherent cell lines also providing in vivo delivery to mouse spleen and bone marrow tissues through tail-vein administration. We dis  ...[more]

Similar Datasets

| S-EPMC7406478 | biostudies-literature
| S-EPMC4111939 | biostudies-literature
| S-EPMC7613708 | biostudies-literature
| S-EPMC4939975 | biostudies-literature
| S-EPMC4077924 | biostudies-literature
| S-EPMC3740846 | biostudies-other
| S-EPMC3814166 | biostudies-literature
| S-EPMC3972625 | biostudies-other
| S-EPMC3815988 | biostudies-literature
| S-EPMC3490019 | biostudies-literature